Extracted from Japanese Konjac and standardized in phytoceramides, SKIN-CERA® is a 100
The active ingredient is supported with both oral and topical clinical results*:
– Oral prospective clinical study:
A single-blind parallel placebo-controlled prospective oral study was performed on 40 subjects during 6 weeks (+2 weeks post-treatment follow-up) to evaluate the efficacy of SKIN-CERA® (2x50mg/day) to improve skin health and monitor potential adverse effects. At each visit, subjects received a physical examination, checking of their vital signs, and a skin examination by a dermatologist assessing different parameters (scoring). SKIN-CERA® treatment was shown to be significantly effective on reducing the dryness score, the itching
score, the age-spot score and on increasing the overall dermatological status score.
– Topical clinical study:
A double-blind randomized topical clinical study was performed on 34 subjects during 12 weeks to evaluate the efficacy of SKIN-CERA® (1
The ingredient can be used in both oral and topical applications in various delivery oral formats like tablets, capsules and softgels, and topical creams, making it easier to meet different consumer preferences. It is ideal for combined “in&out” concepts. SKIN-CERA® is US Patented, allergen free, non-GMO, and suitable for vegan.
* Results based on independent studies conducted by Vidya Herbs Pvt Ltd. Results are not validated by US FDA or EFSA.
